Hospital Medicine

Meaningful change thresholds in POEM and DLQI scores have been established for adolescents and adults.

Seres expects to move forward with plans for SER-109 as a novel treatment for CDI.

A panel of retinal experts developed definitions for and classified the reasons behind patient nonadherence and nonpersistence.

Researchers compare 9 commonly used thermal care interventions for reduced core body temperatures.

Resolution of iron deficiency was associated with lower mortality; however, mortality risk was similar following resolution of anemia.

The US is closing in on the goal of having 70% of adults vaccinated by July 4.

The oral combination therapy can also be used as acute treatment for manic or mixed episodes.

Derek Jones, VP Enterprise Strategy, Americas at Deputy, gives tips on staffing strategies.

W. Schuyler Jones, MD, and Manesh Patel, MD discuss the influences the aspirin-dosing cardiology trial may have on future studies.

The US has reached the 50% mark for vaccinations for adults.

The company expects to file for FDA authorization for the 12-17 year old population in June.

Multiple studies have found a decrease in CDI rates during the COVID-19 pandemic in comparison to previous years.

Esophageal cancer has a low survival rate largely due to advanced stage diagnosis.

Arena Pharmaceuticals expects to move forward with later phase clinical trials testing etrasimod.

Direct optical endoscopy are often underutilized in screenings for EAC.

COVID-19 patients with liver injuries are at a higher risk of mortality or lengthier hospital stays.

About a quarter of Cologuard's ordered by patients are deemed to be inappropriate.

C difficile and sepsis infections can be especially difficult to treat.

SER-109 resulted in a 73% reduction in relative risk for CDI over 8 weeks.

There is a substantial health care cost for CDI patients with sepsis.

The researchers developed a computerized clinical decision support tool to help clinicians prescribe probiotics.

A large proportion of HCV patients remain undiagnosed, particularly in the older population.

Vonoprazan has shown more potent acid inhibitory effects than PPI.

Early data suggests vaccines are effective against B.1.617.2 variant first discovered in India.

Pegcetacoplan outperformed competitor in a phase 3 head-to-head study.